In today’s session CVS Health Corp (CVS) registered an unusually high (3,086) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the February, 2017 call, expecting serious CVS increase. With 3,086 contracts traded and 3214 open interest for the Feb, 17 contract, it seems this is a quite bullish bet. The option with symbol: CVS170217C00070000 closed last at: $5.4 or 0.9% up. About 3.97 million shares traded hands. CVS Health Corp (NYSE:CVS) has declined 27.36% since April 25, 2016 and is downtrending. It has underperformed by 33.37% the S&P500.
Analysts await CVS Health Corp (NYSE:CVS) to report earnings on February, 14. They expect $1.67 earnings per share, up 9.15% or $0.14 from last year’s $1.53 per share. CVS’s profit will be $1.79 billion for 11.17 P/E if the $1.67 EPS becomes a reality. After $1.64 actual earnings per share reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 1.83% EPS growth.
CVS Health Corp (NYSE:CVS) Ratings Coverage
Out of 15 analysts covering CVS Health (NYSE:CVS), 11 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 73% are positive. CVS Health has been the topic of 23 analyst reports since July 22, 2015 according to StockzIntelligence Inc. Barclays Capital reinitiated it with “Overweight” rating and $115 target price in Thursday, March 10 report. Oppenheimer maintained CVS Health Corp (NYSE:CVS) rating on Friday, August 28. Oppenheimer has “Outperform” rating and $119.0 price target. The firm earned “Buy” rating on Wednesday, August 19 by Evercore. The stock of CVS Health Corp (NYSE:CVS) has “Outperform” rating given on Friday, January 22 by Robert W. Baird. As per Wednesday, August 5, the company rating was maintained by RBC Capital Markets. Morgan Stanley downgraded it to “Equal-Weight” rating and $104 target price in Monday, June 20 report. The rating was initiated by UBS on Thursday, October 6 with “Buy”. The stock of CVS Health Corp (NYSE:CVS) has “Buy” rating given on Thursday, June 23 by Mizuho. The firm has “Buy” rating given on Thursday, May 12 by Jefferies. Oppenheimer maintained CVS Health Corp (NYSE:CVS) rating on Thursday, December 17. Oppenheimer has “Outperform” rating and $117 price target.
According to Zacks Investment Research, “CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.”
Insitutional Activity: The institutional sentiment decreased to 0.98 in Q2 2016. Its down 0.02, from 1 in 2016Q1. The ratio fall, as 67 funds sold all CVS Health Corp shares owned while 574 reduced positions. 97 funds bought stakes while 544 increased positions. They now own 833.68 million shares or 6.91% less from 895.55 million shares in 2016Q1.
Brown Advisory holds 0.06% of its portfolio in CVS Health Corp (NYSE:CVS) for 188,895 shares. First Corp In holds 0.35% of its portfolio in CVS Health Corp (NYSE:CVS) for 6,397 shares. Hutchinson Cap Ca has 157,421 shares for 4.57% of their US portfolio. Segall Bryant Hamill Lc last reported 0.03% of its portfolio in the stock. Shufro Rose And Llc holds 15,125 shares or 0.16% of its portfolio. Santa Barbara Asset Mngmt Limited Co has invested 2.79% of its portfolio in CVS Health Corp (NYSE:CVS). Bank Of New York Mellon Corporation, a New York-based fund reported 10.44 million shares. Mu Investments Limited holds 0.07% or 1,150 shares in its portfolio. Veritas Invest Management Llp last reported 492,176 shares in the company. Congress Asset Ma accumulated 72,986 shares or 0.16% of the stock. Utd Cap Advisers Limited Com, a California-based fund reported 78,290 shares. Gam Ag reported 502,188 shares or 0.75% of all its holdings. Forte Cap Ltd Liability Corporation Adv owns 46,895 shares or 1.74% of their US portfolio. Boston Advsr Limited Company holds 1.07% of its portfolio in CVS Health Corp (NYSE:CVS) for 446,163 shares. Weybosset & Mgmt Llc last reported 5,650 shares in the company.
CVS Health Corporation, together with its subsidiaries , is a pharmacy company. The company has a market cap of $80.02 billion. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. It has a 15.92 P/E ratio. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
CVS Company Profile
CVS Health Corporation, incorporated on August 22, 1996, together with its subsidiaries (CVS Health), is a pharmacy company. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics.
More news for CVS Health Corp (NYSE:CVS) were recently published by: Fool.com, which released: “CVS Health Corporation Lowers Guidance Due to Recent Walgreens Wins” on November 08, 2016. Fool.com‘s article titled: “Is CVS Health a Buffett Stock?” and published on November 23, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.